Stay informed, stay ahead.
Tom Stubbs, a male Pilates participant, reflects on his experiences in predominantly female classes. He questions whether the language used in instruction, often centered around female anatomy, contributes to the perception that Pilates doesn’t resonate with men. Stubbs shares instances where female instructors have used phrases like “protect the crown jewels,” leading to confusion about…
A new survey of 2,000 Spaniards aged 30 to 50 finds that 7 in 10 fear cognitive decline more than physical changes linked to ageing. Only about 15% of respondents say physical signs like wrinkles are their main concern. On the other hand, 87% believe society still focuses on appearance, but 95% say their priority…
A tiny retinal implant is giving new hope to people who have lost their central vision due to advanced macular disease. In a recent clinical trial, the micro-device — no bigger than a grain of rice — helped many patients read again after years of blindness. The implant was tested on patients with geographic atrophy,…
A fitness method from Japan called “Japanese walking,” which alternates between fast and slow walking intervals, is gaining traction worldwide as a quick, practical workout. Originally developed in Japan for older adults, the technique asks walkers to speed up for about three minutes, then slow down for three minutes, repeating the cycle for about 30…
Out-of-pocket health payments make up roughly 15% of total health spending in the European Union, EU statistics show. Across 34 European countries, the share varies widely. In Luxembourg, households paid just 8.5% of health-care costs, while in Bulgaria that figure reached 35.5%. Higher costs tend to hit Eastern and Southern Europe hardest. Countries like Latvia,…
The U.S. Food & Drug Administration (FDA) has approved a new therapy from Glaukos Corporation, offering a less painful treatment for a rare eye condition called keratoconus. Keratoconus causes the cornea to thin and bulge, which leads to vision loss if untreated. Glaukos’ new topical therapy aims to treat this condition without the need for…
Merck has begun work on a $3 billion manufacturing facility in Elkton, Virginia, as part of its plan to ramp up U.S. production. The new plant will span about 400,000 square feet and focus on small-molecule drug manufacturing and testing. Merck said the investment will create over 500 full-time jobs and roughly 8,000 construction roles…
Fiji has achieved a major health milestone. The World Health Organization (WHO) has officially validated Fiji’s elimination of Trachoma as a public health problem. This makes Fiji the 26th nation globally to reach this goal and the 58th to eliminate at least one neglected tropical disease. Trachoma, caused by the bacterium Chlamydia trachomatis, spreads through…
Uruguay has passed a landmark law legalising euthanasia and assisted dying for terminally ill patients. The legislation was approved after a 20–11 vote in the Senate, marking a historic shift in Latin America’s approach to end-of-life care. Under the new law, eligible adults with a terminal illness may choose medically assisted death if they meet…
Researchers have found early signs that an mRNA vaccine — like those used for COVID-19 — could help the immune system fight certain cancers. In a study involving more than 1,000 patients with advanced lung or skin cancer, people who received an mRNA vaccine within 100 days of starting immunotherapy lived significantly longer. This suggests…
